All News #Library
Others
TiumBio Doses First Patient In Phase 2 Trial Of TU2218
04 Oct 2024 //
PR NEWSWIRE
TiumBio Positive Topline Phase 2a Data For Merigolix In Endometriosis
08 May 2024 //
PR NEWSWIRE
TiumBio Secures KRW 38.5 Billion in Anticipation of Upcoming Clinical Data
29 Dec 2023 //
PR NEWSWIRE
TiumBio and Hansoh Announce Trial Approval of `HS-10518/TU2670`
05 Jul 2023 //
PR NEWSWIRE
TiumBio inks licensing deal with China`s Hansoh for endometriosis drug
10 Aug 2022 //
KEDGLOBAL

Market Place
Sourcing Support